Starpharma Holdings Ltd
ASX:SPL
Starpharma Holdings Ltd
ASX:SPL
Price:
0.12 AUD
Market Closed
Updated:
May 5, 2024
Starpharma Holdings Ltd
Cash from Financing Activities
|
Starpharma Holdings Ltd
Cash from Financing Activities Peer Comparison
Comparables:
MYX
NEU
BOT
PBP
C
CU6
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Starpharma Holdings Ltd
ASX:SPL
|
Cash from Financing Activities
-AU$5.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-192%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Financing Activities
-AU$431.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Financing Activities
AU$3.6m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-18%
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Financing Activities
AU$36.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
46%
|
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Financing Activities
-AU$11.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Financing Activities
AU$231.6k
|
CAGR 3-Years
-70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Starpharma Holdings Ltd's Cash from Financing Activities?
Cash from Financing Activities
-5.5m
AUD
-5.5m
AUD
Based on the financial report for Dec 31, 2023, Starpharma Holdings Ltd's Cash from Financing Activities amounts to -5.5m AUD.
What is Starpharma Holdings Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-192%
-192%
You don't have any saved screeners yet
